SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Geopolitical tensions involving Iran and the Strait of Hormuz, along with resulting oil-price volatility, are driving attention to Carnival as traders debate the impact of fuel costs and travel demand. The community is split between bearish concerns over continued selling and war-related disruption and bullish views that strong bookings, earnings execution, debt reduction, buybacks, and the reinstated dividend make the shares undervalued.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Anticipation around DFINITYs reported UNDP sovereign-cloud and AI pilot initiatives, alongside ICP product rollouts such as MCP Server, Caffeine, Cloud Engines and MultiDEX, is driving attention. Bulls view these developments as potential real-world adoption catalysts, while skeptics argue the pilots remain unproven and that weak usage, revenue, inflation and tokenomics continue to weigh on ICP.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Renewed interest in advanced nuclear and microreactor stocks is driving attention, with traders highlighting U.S. military support for small reactors and speculation around Nano Nuclears potential UAE deployment or investment discussions. Bulls point to AI data-center power demand and government validation, while skeptics cite the companys pre-revenue status, speculative valuation, and broader sector weakness.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

Quarterly results that exceeded expectations, higher adjusted EBITDA guidance, and a new multi-year DefenCath supply agreement with an additional large dialysis operatorwidely believed by traders to be DaVitaare driving attention. The bullish reaction is tempered by debate over the post-TDAPA reimbursement decline, limited 2027 guidance, and the uncertain timing of Medicare Advantage adoption, while the pending REZZAYO prophylaxis filing adds another potential catalyst.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

Kentucky regulators approved power service for up to 482 MW at TeraWulfs Justified data center campus, reinforcing its shift from Bitcoin mining toward AI/HPC infrastructure tied to an Anthropic lease. Traders remain divided: bulls view the approval and scarce power access as long-term positives, while bears focus on financing, construction and execution risks and the stocks weak reaction to the news.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

FDA approval of Revolution Medicines once-daily daraxonrasib (Rasonque) for metastatic pancreatic cancer, supported by a substantial survival benefit in Phase 3, is driving attention. Traders are largely bullish on its commercial potential and broader RAS-oncology platform, though some argue the approval was already priced in and cite valuation, side effects, access concerns, and a sell-the-news reaction.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Speculation around larger LUNC burns, Market Module 2.0, a potential USTC repeg, and new Terra Classic ecosystem projects is driving attention, with traders framing these developments as a possible recovery catalyst. Bullish holders expect reduced supply and renewed utility, while skeptics point to weak volume, heavy supply, wallet issues, and the lack of confirmed exchange-listing or burn announcements.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

New REDUCE-IT Legacy data presented at ESC, suggesting cardiovascular benefits from icosapent ethyl may persist after treatment, has renewed interest in Vascepas clinical value. Traders remain divided, with some viewing the findings and improving China and international demand as supportive, while others dismiss the analysis as recycled and focus on Sarissas reported stake reduction, generic competition, and the lack of share-price response.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas personalized mRNA melanoma vaccine, used with Keytruda, met its Phase 3 recurrence-free and distant-metastasis-free survival endpoints, strengthening sentiment around Mercks oncology pipeline and helping drive the shares to 52-week highs. Traders remain divided over how much value to assign before full data, regulatory review and clarity on the therapys broader potential, particularly given Keytrudas future patent-cliff risk.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

A strong quarterly performance and BioCrysts plan to use Orladeyo-generated cash to acquire additional rare-disease assets are driving attention, alongside speculation about a potential takeover. Traders remain divided, with bullish investors emphasizing Orladeyos profitability, navenibart and pipeline optionality, while skeptics cite competition, dilution, limited near-term catalysts and stagnant price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
